- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.57 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x DTQ: 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE(Non-covalent)
- 14 x FMT: FORMIC ACID(Non-functional Binders)
FMT.2: 9 residues within 4Å:- Chain A: G.1, P.2, L.3, S.4
- Chain B: Q.197, L.210, F.211, H.213, F.248
4 PLIP interactions:1 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:Q.197, A:G.1, A:L.3, A:S.4
FMT.3: 7 residues within 4Å:- Chain A: R.160, L.182, R.184, K.194, G.198, R.199, I.200
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.160, A:R.160, A:R.199
FMT.4: 5 residues within 4Å:- Chain A: K.29, L.31, K.41, Y.107
- Ligands: DTQ.1
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.29, A:Y.107
FMT.5: 4 residues within 4Å:- Chain A: I.207, F.211, K.252, Q.277
No protein-ligand interaction detected (PLIP)FMT.6: 6 residues within 4Å:- Chain A: Q.150, A.153, T.217, V.284, F.285, A.286
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:F.285, A:A.286
FMT.7: 4 residues within 4Å:- Chain A: E.19, F.20, H.46, K.48
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:H.46, A:K.48
FMT.8: 2 residues within 4Å:- Chain A: K.41, T.55
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.41
FMT.10: 9 residues within 4Å:- Chain A: Q.197, L.210, F.211, H.213, F.248
- Chain B: G.1, P.2, L.3, S.4
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:G.1, B:L.3, B:S.4, A:Q.197
FMT.11: 7 residues within 4Å:- Chain B: R.160, L.182, R.184, K.194, G.198, R.199, I.200
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.160, B:R.160, B:R.199
FMT.12: 5 residues within 4Å:- Chain B: K.29, L.31, K.41, Y.107
- Ligands: DTQ.9
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:K.29
FMT.13: 4 residues within 4Å:- Chain B: I.207, F.211, K.252, Q.277
No protein-ligand interaction detected (PLIP)FMT.14: 6 residues within 4Å:- Chain B: Q.150, A.153, T.217, V.284, F.285, A.286
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:F.285, B:A.286
FMT.15: 4 residues within 4Å:- Chain B: E.19, F.20, H.46, K.48
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:H.46, B:K.48
FMT.16: 2 residues within 4Å:- Chain B: K.41, T.55
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.41, B:T.55
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Newton, R. et al., The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity. Eur J Med Chem (2016)
- Release Date
- 2016-02-17
- Peptides
- PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.57 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x DTQ: 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE(Non-covalent)
- 14 x FMT: FORMIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Newton, R. et al., The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity. Eur J Med Chem (2016)
- Release Date
- 2016-02-17
- Peptides
- PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A